96910 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used Muscle proteins, e.g. myosin, actin
MEDIUM, METHODS, CELLS AND SECRETED FACTORS FOR STEM CELL CULTURE AND THERAPY
#2ENGINEERED NUCLEIC ACID REGULATORY ELEMENTS AND METHODS AND USES THEREOF
#3Method of Erasing Abnormal Epigenetic Modification in Ovine iCHI Embryo and Use in Generating Gene-Edited Sheep
#4MYOSTATIN PROTEIN MUTANT AND PREPARATION METHOD THEREOF
#5DESMIN TYROSINE PHOSPHORYLATED MUTANT AND PANCREATIC CANCER
#6GENE THERAPIES FOR USHER SYNDROME (USH1B)
#7APPLICATION FOR PIR-HSA-164586 AND MYH9
#8A TRUNCATED PROTEIN AND USE THEREOF
#9DUAL AAV-MYO7A VECTORS WITH IMPROVED SAFETY FOR THE TREATMENT OF USH1B
#10MICRO-DYSTROPHINS AND RELATED METHODS OF USE
#11MUSCLE TROPIC RAAV
#12COMPOSITIONS AND METHODS FOR THIN FILAMENT MODULATION
#13MYOSIN 15 PROMOTERS AND USES THEREOF
#14MYOSIN 15 PROMOTERS AND USES THEREOF
#15METHODS OF ON DEMAND IN VIVO PHOTOTAGGING
#16MICROBIAL PRODUCTION OF TITIN FIBERS WITH EXCEPTIONAL MECHANICAL PERFORMANCE
#17METHODS AND COMPOSITIONS FOR TREATING TNNT2 RELATED CARDIOMYOPATHY WITH A VIRAL VECTOR
#18METHODS AND COMPOSITIONS FOR TREATING OR AMELIORATING CARDIAC MUSCLE ARRHYTHMIAS AND SKELETAL MUSCLE TREMORS
#19COMPOSITIONS AND METHODS FOR PRODUCING FOOD PRODUCTS WITH RECOMBINANT ANIMAL PROTEIN
#20GENE THERAPY FOR ARRHYTHMOGENIC CARDIOMYOPATHY
#21ADENO-ASSOCIATED VIRUS VECTOR DELIVERY OF ALPHA-SARCOGLYCAN AND THE TREATMENT OF MUSCULAR DYSTROPHY
#22SYSTEMIC ADMINISTRATION OF CIRCULAR RNA POLYNUCLEOTIDES ENCODING MUSCLE PROTEINS OR PROTEIN COMPLEXES
#23COMPOSITIONS AND METHODS FOR USING ACTIN-BASED PEPTIDES TO MODULATE CELLULAR BIOACTIVITY AND CELLULAR SUSCEPTIBILITY TO INTRACELLULAR PATHOGENS
#24COMPOSITIONS COMPRISING KOZAK SEQUENCES SELECTED FOR ENHANCED EXPRESSION
#25MYOPEPTIDES AND METHODS OF USE IN TREATING HEART FAILURE
#26POLYPEPTIDES, NUCLEIC ACID MOLECULES, COMPOSITIONS, AND RELATED METHODS
#27ANTIGEN-BINDING MOLECULE
#28METHODS OF INCREASING STRENGTH AND FUNCTIONALITY WITH GDF8 INHIBITORS
#29ANTIGEN-BINDING MOLECULE SPECIFICALLY BINDING TO HGFR AND EGFR, AND PHARMACEUTICAL USE THEREOF
#30PROMOTER-ENHANCER SEQUENCES OF THE HUMAN TROPONIN T GENE FOR SELECTIVE EXPRESSION IN CARDIAC MYOCYTES
#31MEDIUM, METHODS, CELLS AND SECRETED FACTORS FOR STEM CELL CULTURE AND THERAPY
#32RECOMBINANT HERPESVIRALES VECTOR
#33MATERIALS AND METHODS FOR NEUROFIBROMIN 2/MERLIN (NF2) GENE THERAPY
#34ADENO-ASSOCIATED VIRUS VECTOR DELIVERY OF B-SARCOGLYCAN AND MICRORNA-29 AND THE TREATMENT OF MUSCULAR DYSTROPHY
#35NUCLEOTIDE EDITING TO REFRAME DMD TRANSCRIPTS BY BASE EDITING AND PRIME EDITING
#36DYSTROPHIN CONSTRUCTS CONTAINING R11-R12
#37COMPOSITIONS AND METHODS FOR TREATING OBESITY
#38GENE-THERAPY VECTORS FOR TREATING CARDIOMYOPATHY
#39PSEUDOTYPED PARTICLES, MODIFIED CELLS, RELATED COMPOSITIONS, AND RELATED METHODS
#40MATERIALS AND METHODS FOR DELIVERING NUCLEIC ACIDS TO COCHLEAR AND VESTIBULAR CELLS
#41CSRP3 (CYSTEINE AND GLYCINE RICH PROTEIN 3) GENE THERAPY
#42MATERIALS AND METHODS FOR TREATMENT OF TITIN-BASED MYOPATHIES AND OTHER TITINOPATHIES
#43MUSCLE-SPECIFIC NUCLEIC ACID REGULATORY ELEMENTS AND METHODS AND USE THEREOF
#44GENE-THERAPY VECTORS FOR TREATING CARDIOMYOPATHY
#45EXPRESSION SYSTEMS, RECOMBINANT CELLS AND USES THEREOF
#46TRANSGENIC PLANTS COMPRISING MYOGLOBIN AND METHODS FOR PRODUCING MYOGLOBIN IN TRANSGENIC PLANTS
#47DUAL AAV-MYO7A VECTORS WITH IMPROVED SAFETY FOR THE TREATMENT OF USH1B
#48NEW POLYPEPTIDE COMPLEX
#49COMPOSITIONS AND METHODS RELATING TO MYOMAKER-INDUCED MUSCLE CELL FUSION
#50VECTOR SYSTEM
#51Myosin Derived Peptides and Related Compounds with Anticoagulant Activities
#52Methods of prognosis and treatment
#53COMBINATION OF DIETARY PEPTIDES
#54Adeno-associated virus vector delivery of alpha-sarcoglycan and the treatment of muscular dystrophy
#55COMPOSITIONS AND METHODS FOR TREATING SENSORINEURAL HEARING LOSS USING OTOFERLIN DUAL VECTOR SYSTEMS
#56ADENO-ASSOCIATED VIRUS VECTOR DELIVERY OF B-SARCOGLYCAN AND MICRORNA-29 AND THE TREATMENT OF MUSCULAR DYSTROPHY
#57NOVEL ANTI-TROPONINT ANTIBODIES
#58GENE THERAPIES FOR USHER SYNDROME (USH1B)
#59DYSTROPHIN R16/R17 SYNTROPHIN PDZ FUSION PROTEINS
#60ANTITUMOR CELL COMPRISING A CHARGE MODIFIED GLOBIN
#61METHODS AND COMPOSITIONS FOR RAPIDLY REPLACING CARDIAC MYOSIN BINDING PROTEIN-C IN SARCOMERES
#62SYNTHETIC BI-EPITOPE COMPOUND
#63Myosin 15 promoters and uses thereof
#64FIBER ASSEMBLY AND USE THEREOF
#65COMPOSITIONS AND METHODS FOR USING ACTIN-BASED PEPTIDES TO MODULATE CELLULAR BIOACTIVITY AND CELLULAR SUSCEPTIBILITY TO INTRACELLULAR PATHOGENS
#66ADENO-ASSOCIATED VIRUS VECTOR DELIVERY OF MUSCLE SPECIFIC MICRO-DYSTROPHIN TO TREAT MUSCULAR DYSTROPHY
#67Polypeptides, nucleic acid molecules, compositions, and related methods
#68Methods for increasing lean body mass with an exercise regimen and a GDF8 inhibitor that is an anti-GDF8 antibody
#69Myosin 15 promoters and uses thereof
#70METHOD FOR EFFICIENTLY PRODUCING ß MYOSIN HEAVY CHAIN IN CARDIAC MUSCLE CELLS DIFFERENTIATED FROM INDUCED PLURIPOTENT STEM CELLS DERIVED FROM HOMO SAPIENS
#71DUAL-AAV VECTOR-BASED SYSTEMS AND METHODS FOR DELIVERING OVERSIZED GENES TO MAMMALIAN CELLS
#72GDF-15 and/or troponin T for predicting kidney failure in heart surgery patients
#73Gene-therapy vectors for treating cardiomyopathy
#74Micro-dystrophins and related methods of use
#75MYOMERGER POLYPEPTIDES, NUCLEIC ACID MOLECULES, CELLS, AND RELATED METHODS
#76NOVEL MICRO-DYSTROPHINS AND RELATED METHODS OF USE
#77COMPOSITIONS AND METHODS RELATING TO MYOMIXER-PROMOTED MUSCLE CELL FUSION
#78Compositions and methods relating to myomaker-induced muscle cell fusion
#79Circulating Angiopoietin-2 (Ang-2) for the prediction of recurrence of atrial fibrillation
#80Materials and methods for delivering nucleic acids to cochlear and vestibular cells
#81Cancer-treating recombinant protein that improves the activity of cytotoxic killer cells targeting cancer cells and use thereof
#82Junctophilin-2 fragments and uses therefor
#83Somatic opsins for single cell resolution optogenetics
#84NOVEL BETA-ACTIN AND RPS21 PROMOTERS AND USES THEREOF
#85Methods of prognosis and treatment
#86Adeno-associated virus vector delivery of B-sarcoglycan and microrna-29 and the treatment of muscular dystrophy
#87Modified dystrophin proteins
#88Dual-AAV vector-based systems and methods for delivering oversized genes to mammalian cells
#89COMPOSITIONS AND METHODS FOR TISSUE REPAIR
#90Engineered microbes for rare earth element adsorption
#91COMPOSITION HAVING COVERED FIBROUS PROTEIN ANTIGENIC PROPERTIES AND PRODUCTION METHOD THEREFOR
#92Medium, methods, cells and secreted factors for stem cell culture and therapy
#93Anti-MYL9 antibody
#94Inflammatory Disease Treatment Composition Including Anti-Myosin Regulatory Light-Chain Polypeptide Antibody
#95Repairing a mutant human titin gene using CRISPR technology
#96Peptides derived from myosin 19 and methods of use thereof
#97DETECTION OF ACUTE MYOCARDIAL INFARCTION
#98Method for efficiently producing β myosin heavy chain in cardiac muscle cells differentiated from induced pluripotent stem cells derived from
#99SARCOMERE BIOSENSOR AND METHODS OF USE THEREOF
#100BIOMARKER FOR CARDIAC DISORDERS
#101β-actin promoters and uses thereof
#102Compositions and methods for using actin-based peptides to modulate cellular bioactivity and cellular susceptibility to intracellular pathogens
#103Polypeptide complex of titin-telethonin beta-pleated sheet structure as polypeptide drug carrier, method of using the polypeptide complex, and fusion protein complex thereof
#104Methods for treating and preventing cardiomyopathy with a fusion protein of tafazzin and a cellular permeability peptide
#105Microdystrophin peptides and methods for treating muscular dystrophy using the same
#106Method for identifying a compound useful with myosin regulatory light chain polypeptide antibody for treatment of an inflammatory disease
#107Cardiac troponin I ultra-sensitive detection reagent kit, and ultra-sensitive detection method therefor
#108Synthetic bi-epitope compound
#109PROCESS OF AFOD AND AFCC AND MANUFACTURING AND PURIFICATION PROCESSES OF PROTEINS
#110Diagnostic and therapeutic uses of gelsolin in renal failure
#111COMPOSITIONS AND METHODS FOR MODULATING NEURONAL DEGENERATION
#112Methods and compositions for expressing functional class XIV myosin
#113Directed evolution and in vivo panning of virus vectors
#114Methods for increasing lean body mass with resistance training and a GDF8 inhibitor that is an anti-GDF8 antibody
#115Biomarker for cardiac disorders
#116Fluorescent protein
#117Cell and gene based methods to improve cardiac function
#118Peptides derived from myosin 19 and methods of use thereof
#119Compositions and methods relating to myomaker-induced muscle cell fusion
#120Role of a cluster of long noncoding RNA transcripts in protecting the heart from pathological hypertrophy
#121Gene-therapy vectors for treating cardiomyopathy
#122Inflammatory disease treatment composition including anti-myosin regulatory light-chain polypeptide antibody
#123TNNT1 mini-promoters
#124Methods and compositions for expressing functional class XIV myosin
#125Directed evolution and in vitro panning of virus vectors
#126Method for obtaining three-dimensional actin structures and uses thereof
#127β-actin and RPS21 promoters and uses thereof
#128Bin1 as a prognostic marker in cardiovascular disease
#129In vitro assessment of cardiovascular events by assay for neo-eptitopes of titin protein
#130Dual-AAV vector-based systems and methods for delivering oversized genes to mammalian cells
#131Directed evolution and in vitro panning of virus vectors
#132Microdystrophin peptides and methods for treating muscular dystrophy using the same
#133Method for acquiring a heat-stable antibody-displayed phage
#134Inhibition of MyBP-C binding to myosin as a treatment for heart failure
#135Nitrated cardiac troponin I as a biomarker of cardiac ischemia
#136Myomegalin variant 8
#137Methods and compositions for gene therapy and GHRH therapy
#138Plant with enhanced growth and method for producing the same
#139Diagnostic method for Alzheimer's disease
#140Constructs for enhancement of gene expression in muscle
#141Cardiac-specific nucleic acid regulatory elements and methods and use thereof
#142GDF-15 and/or Troponin T for Predicting Kidney Failure in Heart Surgery Patients
#143Motor proteins propelling nano-scale devices and systems
#144COMPOSITIONS AND MODULATION OF MYOCYTE ENHANCER FACTOR 2 (MEF2)
#145PRRS-VIRUS RECEPTOR AND ITS INHIBITOR
#146Molecular motor
#147Bin1 as a Prognostic Marker in Cardiovascular Disease
#148ANTIBODIES TO TROPONIN I AND METHODS OF USE THEREOF
#149ANLN PROTEIN AS AN ENDOCRINE TREATMENT PREDICTIVE FACTOR
#150PEPTIDE ANTAGONISTS OF ZONULIN AND METHODS FOR USE OF THE SAME
#151Myocardial peptide, preparation method and uses thereof
#152GENETICALLY ENCODED CALCIUM SENSORS COMPRISING THE C-TERMINAL LOBE OF TROPONIN C AND A FLUORESCENCE TAG
#153Snapin and methods for regulation of microtubule assembly and dendrite growth and branching
#154Directed evolution and in vivo panning of virus vectors
#155Chemoprevention of colorectal cancer by mesalamine/sulfasalazine
#156Recombinant production of authentic human proteins using human cell expression systems
#157Compositions and methods for tissue repair
#158Crosslinking within coordination complexes
#159Detection conjugate
#160Antibodies to troponin I and methods of use thereof
#161Compositions and methods for retinal transduction and photoreceptor specific transgene expression
#162Motor proteins propelling nano-scale devices and systems
#163Double-muscling in mammals
#164Application of actin-binding protein to disease associated with cell motility
#165Substrates of N-end rule ubiquitylation and methods for measuring the ubiquitylation of these substrate
#166Nuclear targeting sequence
#167Diagnostic and therapeutic uses of gelsolin in renal failure
#168Repressor of skeletal muscle differentiation, nucleic acids coding therefor and the use thereof in diagnosis and therapy
#169Compositions and methods to modulate cell membrane resealing
#170METHODS OF INHIBITING ANGIOGENESIS WITH FRAGMENTS AND HOMOLOGS OF TROPONIN SUBUNIT I
#171NEW GENE FRAGMENT, NOVEL TRANSGENIC ZEBRAFISH AND METHODS FOR PRODUCING TRANSGENIC ZEBRAFISH
#172Stimulating neurite outgrowth using Tctex-1-related polypeptides
#173PEPTIDE ANTAGONISTS OF ZONULIN AND METHODS FOR USE OF THE SAME
#174Snapin and methods for regulation of microtubule assembly and dendrite growth and branching
#175Genetically encoded bioindicators of calcium-ions
#176Beta-actin and RPS21 promoters and uses thereof
#177Synthetic peptides that cause F-actin bundling and block actin depolymerization
#178Compositions and methods for regulating cardiac performance
#179Nucleic acid constructs
#180Molecular motor
#181Biologically active peptide VAPEEHPTLLTEAPLNPK derivatives
#182Actin proteins as biomarkers for indication and targeting of resistance and sensitivity to an Abl kinase inhibitor in patients with chronic myelogenous leukemia
#183Method for treating or inhibiting intestinal inflammation
#184Pharmaceutical compositions comprising fragments and homologs of troponin subunits
#185Novel Promoters
#186Protein composition obtained from a muscle source
#187Tropomyosin isoforms, and diagnostic and therapeutic uses therefor
#188Tctex-1-related polypeptides
#189Cardio myopeptidin, the production and the use thereof
#190Determining drug resistance
#191Stabilization of cardiac troponin
#192Novel fluorescent Cichlid and method for producing thereof
#193Double-muscling in mammals
#194Repressor of skeletal muscle differentiation, nucleic acid coding therefor and the use thereof in diagnosis and therapy
#195Cytoplasmic dynein heavy chain 1 genes, expression products, non-human animal model uses in human neurological diseases
#196Pharmaceutical composition and method for inhibiting gastrointestinal inflammation
#197Compositions and methods for inhibiting liver stellate cell growth
#198Regulation of cell surface proteins
#199Inducible site-directed mutagenesis through conditional gene rescue
#200Methods of inhibiting angiogenesis with fragments and homologs of troponin subunit 1
#201Compositions and methods for preventing, treating and diagnosing diabetes
#202Three-dimensional structures of HDAC9 and Cabin1 and compound structures and methods related thereto
#203Affinity purification system using troponin molecules as affinity ligands
#204Repeat sequence protein polymer active agent congjugates, methods and uses
#205Nuclear targeting sequence
#206Zebrafish assay
#207Purification of Arp2/3 complex and compositions containing purified Arp2/3 complex
#208Common marmoset-derived beta-actin gene and use thereof
#209Diagnosis and treatment of myocardial failure
#210Peptide antagonists of zonulin and methods for use of the same
#211Myocardial grafts and cellular compositions useful for same
#212Modulators of B-lymphocyte activation, myosin-1F compositions and methods of use
#213Methods for stabilizing proteins
#214Human smooth muscle myosin heavy chain
#215Cell surface tropomyosin as a target of angiogenesis inhibition
#216Compositions and methods for treating inflammatory disorders
#217Nanofabrication using actin filaments
#218Methods for diagnosing and treating heart disease
#219Albumin derivatives with therapeutic functions
#220Affinity purification system using troponin molecules as affinity ligands
#221Muscle transcription factors
#222β-actin and rpS21 promoters and uses thereof